• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

New Article Highlights Risk of COVID and Obstructive Sleep Apnea Connection

December 14, 2020 by admin

As of Monday, Dec. 14, the first citizens in the United States (outside of clinical trials) started receiving COVID-19 vaccinations. According to reports, the doses are primarily going to hospital front-line workers in all 50 states. It’s positive news, but any “end” to the pandemic is still months, or perhaps a year, in the future.

Meanwhile, clinicians are examining why some people suffer immensely from COVID while others do not.

According to findings in a new article report, they are finding the culprit of OSA, essentially hiding in plain sight.    “A study published earlier this fall titled “Obstructive Sleep Apnea and Risk of COVID-19 Infection, Hospitalization and Respiratory Failure” concluded that patients with OSA were eight times more likely to be infected with COVID-19 than others of similar age who’d received care from a Chicago-area health system,” The condition also was associated with increased risk of hospitalization and twice the risk of respiratory failure.

Another recent study “Sleep Apnea and COVID-19 Mortality and Hospitalization”analyzed data on more than 4,500 patients with COVID-19 and found that those with sleep apnea had an increased rate of all-cause mortality.”   

In the article, Lastra calls for additional research to assess the impact of OSA treatment on risk for severe COVID-19 illness. “We also need to educate patients about OSA’s link to severe COVID-19 illness, using venues like the media, community outreach events and virtual activities,” she writes. “This effort needs to aim for health equity and include racial and ethnic minority groups who are at disproportionate risk from COVID-19. With patients as partners, more people can seek evaluation and treatment sooner.” 

Click Here to read the full article

Filed Under: Blog, News

Primary Sidebar

More to See

Xywav Oral Solution for Idiopathic Hypersomnia

February 16, 2022 By Alan Hickey

New Insomnia Drug Improves Sleep Outcomes for Adults

February 10, 2022 By Alan Hickey

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • Sleep Hygiene: Which Bedroom Colors to Avoid and which Promote Good Sleep??
  • Xywav Oral Solution for Idiopathic Hypersomnia
  • New Insomnia Drug Improves Sleep Outcomes for Adults
  • Mark Cuban Billionaire Entrepreneur and Television Personality Launches Online Pharmacy for Generic Drugs
  • Americans Say They’re Sleep-Deprived After the Super Bowl

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2022 · Sleep Diagnosis and Therapy